Inspira Technologies Oxy BHN Ltd (NASDAQ:IINN) shares are trading lower by 21.5% to $1.02 Thursday morning. The stock is falling, potentially on profit-taking, after the company on Wednesday announced the approval of a U.S. Patent for its orbiting blood oxygenation delivery system, VORTX, a component of the INSPIRA ART500 device.
Inspira Technologies said this technology is set to disrupt the conventional approach to blood oxygenation by eliminating the need for fiber membranes, thereby minimizing damage to blood cells.
CEO Dagi Ben-Noon views this achievement as a pivotal moment in the company's journey toward enhancing patient care and advancing healthcare technology.
See Also: Treasury Yields Almost Fully Erase Post-Inflation Data Surge
How ...
IINN) Shares?>Full story available on Benzinga.com